Spectracure Ab
Clinical trials sponsored by Spectracure Ab, explained in plain language.
-
Light therapy could offer new option for prostate cancer patients
Disease control Recruiting nowThis early-stage study tests a new treatment for prostate cancer that hasn't spread. It uses a special light-sensitive drug and laser fibers placed into the prostate to destroy cancer cells. About 43 men will take part, and researchers will check safety and how well the treatment…
Phase: PHASE1, PHASE2 • Sponsor: SpectraCure AB • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
New laser therapy targets recurrent prostate cancer without surgery
Disease control Recruiting nowThis study tests a treatment for men whose prostate cancer has come back after radiation. It uses a special drug (verteporfin) that is activated by lasers placed directly into the tumor. The goal is to safely destroy the cancer while avoiding major side effects. About 66 men will…
Phase: PHASE1, PHASE2 • Sponsor: SpectraCure AB • Aim: Disease control
Last updated May 12, 2026 13:43 UTC